BTAI vs FIS · rev $388.0K vs P/E 7.9, rev $6.67B
BioXcel Therapeutics Inc (BTAI) versus Fidelity National Information Services Inc (FIS) — a side-by-side from cached financials, not a winner call.
BioXcel Therapeutics Inc (BTAI) is a drug manufacturers - specialty & generic company listed on US.
Fidelity National Information Services Inc (FIS) is a information technology services company listed on US.
Latest reported BTAI revenue for 2026-06-30 was $388.0K. Net income was -$27.4M. Revenue was up 88.3% from 2026-03-31 to 2026-06-30. BTAI currently screens at market cap $36.1M.
Latest reported FIS revenue for 2026-06-30 was $6.67B. Net income was $2.60B. FIS currently screens at market cap $21.12B and trailing P/E 7.9.
BTAI currently screens at market cap $36.1M. FIS currently screens at market cap $21.12B and trailing P/E 7.9.
Not investment advice. Open the BTAI and FIS stock pages for the full models.
Not investment advice.